Toxic megacolon risk factors: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) |
||
| Line 17: | Line 17: | ||
**Anticholinergic drugs | **Anticholinergic drugs | ||
**[[Narcotics]] | **[[Narcotics]] | ||
**Severe chronic obstructive pulmonary disease | **Severe [[chronic obstructive pulmonary disease]] | ||
**Organ transplantation | **[[Organ transplantation]] | ||
**Cardiothoracic procedures | **Cardiothoracic procedures | ||
**Diabetes mellitus | **[[Diabetes mellitus]] | ||
**Immunosuppression | **Immunosuppression | ||
**Renal failure | **[[Renal failure]] | ||
==References== | ==References== | ||
Revision as of 14:58, 14 November 2017
|
Toxic Megacolon Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxic megacolon risk factors On the Web |
|
American Roentgen Ray Society Images of Toxic megacolon risk factors |
|
Risk calculators and risk factors for Toxic megacolon risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
Common risk factors in the development of toxic negacolon include discontinuation of steroids, use of barium enemas, colonoscopy, chemotherapy, antidiarrheal drugs, anticholinergic drugs, narcotics.
Risk Factors
Common risk factors
- Common risk factors in the development of toxic megacolon include:[1][2][3][4][5][6][7][8]
- Discontinuation of steroids
- Use of barium enemas
- Colonoscopy
- Chemotherapy
- Antidiarrheal drugs
- Anticholinergic drugs
- Narcotics
- Severe chronic obstructive pulmonary disease
- Organ transplantation
- Cardiothoracic procedures
- Diabetes mellitus
- Immunosuppression
- Renal failure
References
- ↑ "Toxic Megacolon: A Review for Emergency Department Clinicians - ScienceDirect".
- ↑ Caprilli R, Vernia P, Colaneri O, Frieri G (1980). "Risk factors in toxic megacolon". Dig. Dis. Sci. 25 (11): 817–22. PMID 6160025.
- ↑ Autenrieth DM, Baumgart DC (2012). "Toxic megacolon". Inflamm. Bowel Dis. 18 (3): 584–91. doi:10.1002/ibd.21847. PMID 22009735.
- ↑ Sayedy, Leena (2010). "Toxic megacolon associatedClostridium difficilecolitis". World Journal of Gastrointestinal Endoscopy. 2 (8): 293. doi:10.4253/wjge.v2.i8.293. ISSN 1948-5190.
- ↑ Earhart, Megan M. (2008). "The Identification and Treatment of Toxic Megacolon Secondary to Pseudomembranous Colitis". Dimensions of Critical Care Nursing. 27 (6): 249–254. doi:10.1097/01.DCC.0000338869.70035.2b. ISSN 0730-4625.
- ↑ Velanovich V, LaPorta AJ, Garrett WL, Richards TB, Cornett PA (1992). "Pseudomembranous colitis leading to toxic megacolon associated with antineoplastic chemotherapy. Report of a case and review of the literature". Dis. Colon Rectum. 35 (4): 369–72.
- ↑ Hinkson PL, Dinardo C, DeCiero D, Klinger JD, Barker RH (2008). "Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile". Antimicrob. Agents Chemother. 52 (6): 2190–5. doi:10.1128/AAC.00041-08. PMC 2415796. PMID 18391047.
- ↑ Byrn JC, Maun DC, Gingold DS, Baril DT, Ozao JJ, Divino CM (2008). "Predictors of mortality after colectomy for fulminant Clostridium difficile colitis". Arch Surg. 143 (2): 150–4, discussion 155. doi:10.1001/archsurg.2007.46. PMID 18283139.